The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting
An Evaluation of the Effectiveness of a Single Dose of Preoperative Ginger on the Incidence of Postoperative Nausea and Vomiting in Patients Undergoing Elective Gynaecological Surgery
1 other identifier
interventional
110
1 country
1
Brief Summary
This study evaluates the effectiveness of ginger on the incidence of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Half the patients were given an oral dose of ginger preoperatively and half received placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Dec 2017
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2018
CompletedFirst Submitted
Initial submission to the registry
July 14, 2018
CompletedFirst Posted
Study publicly available on registry
August 13, 2018
CompletedAugust 13, 2018
August 1, 2018
6 months
July 14, 2018
August 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of post operative nausea or vomiting
The proportion of patient who have any episodes of nausea or vomiting following surgery
12 hours after surgery
Secondary Outcomes (7)
Severity of post operative Nausea and vomiting
12 hours after surgery
Severity of post operative Nausea and vomiting
24 hours after surgery
Severity of post operative Nausea and vomiting
48 hours after surgery
Severity of post operative Nausea and vomiting
12 hours after surgery
Severity of post operative Nausea and vomiting
24 hours after surgery
- +2 more secondary outcomes
Study Arms (2)
Placebo
PLACEBO COMPARATORTwo coloured capsules containing 0.5 mg of cornstarch and flavoured with non-active essence of ginger, given 2 hours before the scheduled start of surgery.
Ginger
EXPERIMENTALTwo coloured capsules containing 0.5g ginger powder, flavoured with non-active essence of ginger, given 2 hours before the scheduled start of surgery.
Interventions
Eligibility Criteria
You may qualify if:
- Age 18 or above
- Undergoing elective intra-abdominal, gynaecological surgery
You may not qualify if:
- Allergy to ginger, ginger by-products or cornstarch
- Gastroesophageal reflux disease (GERD)
- Allergy to any of the Anaesthesia Agents
- Inability to swallow capsules.
- psychiatric illness which prevents patients giving informed consent.
- Psychological which prevents patients giving informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of the West Indies
Kingston, Kng 7, 00000, Jamaica
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hyacinth Harding, DM
UWI, Faculty of medical sciencces
- STUDY DIRECTOR
Andrea Myers, MD
UWI, Faculty of medical sciencces
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Sequentially numbered, sealed, opaque envelopes prepared and opened the evening before the surgery. Tablets containing either placebo or ginger allocated by a person not involved in any other aspect of the study and administered on the morning of surgery.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate lecturer
Study Record Dates
First Submitted
July 14, 2018
First Posted
August 13, 2018
Study Start
December 2, 2017
Primary Completion
June 12, 2018
Study Completion
June 14, 2018
Last Updated
August 13, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make patient data available to other researchers